Neuro-ophthalmological findings in TAFRO syndrome in a patient from South America, a variant of multicentric Castleman’s disease

[1] Takai K(2010)Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly Rinsho Ketsueki 51 320-325

[2] Nikkuni K(2016)Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version Int J Hematol 103 686-692

[3] Shibuya H(2016)Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy Int J Hematol 104 512-518

[4] Hashidate H(2016)TAFRO syndrome associated with EBV and successful triple therapy treatment: case report and review of the literature Case Rep Hematol 2016 4703608-61

[5] Masaki Y(2013)Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012) J Clin Exp Hematop 53 57-105

[6] Kawabata H(2015)Successful treatment of a Caucasian case of multifocal Castleman’s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report Exp Hematol Oncol 4 3-830

[7] Takai K(2014)First European case of TAFRO syndrome associated with Sjogren disease Am J Intern Med 2 102-207

[8] Kojima M(2015)TAFRO syndrome in a patient of south-american descent EJCRIM 9 822-5

[9] Tsukamoto N(1956)Localized mediastinal lymph node hyperplasia resembling thymoma Cancer 55 206-226

[10] Ishigaki Y(2015)Castleman-Kojima disease (TAFRO syndrome) in a Caucasian patient: a rare case report and review of the literature Blood Cells Mol Dis 14 1-240

[1] Takai K(2010)Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly Rinsho Ketsueki 51 320-325

[2] Nikkuni K(2016)Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version Int J Hematol 103 686-692

[3] Shibuya H(2016)Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy Int J Hematol 104 512-518

[4] Hashidate H(2016)TAFRO syndrome associated with EBV and successful triple therapy treatment: case report and review of the literature Case Rep Hematol 2016 4703608-61

[5] Masaki Y(2013)Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012) J Clin Exp Hematop 53 57-105

[6] Kawabata H(2015)Successful treatment of a Caucasian case of multifocal Castleman’s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report Exp Hematol Oncol 4 3-830

[7] Takai K(2014)First European case of TAFRO syndrome associated with Sjogren disease Am J Intern Med 2 102-207

[8] Kojima M(2015)TAFRO syndrome in a patient of south-american descent EJCRIM 9 822-5

[9] Tsukamoto N(1956)Localized mediastinal lymph node hyperplasia resembling thymoma Cancer 55 206-226

[10] Ishigaki Y(2015)Castleman-Kojima disease (TAFRO syndrome) in a Caucasian patient: a rare case report and review of the literature Blood Cells Mol Dis 14 1-240